The 36-month beta value for MLEC is at -0.47. Analysts have varying views on the stock, with 0 analysts rating it as a “buy,” 0 rating it as “overweight,” 0 as “hold,” and 0 as “sell.”
The public float for MLEC is 6.50M, and currently, shorts hold a 0.12% of that float. The average trading volume for MLEC on April 30, 2024 was 1.41M shares.
MLEC) stock’s latest price update
Moolec Science SA (NASDAQ: MLEC)’s stock price has increased by 0.73 compared to its previous closing price of 1.37. However, the company has seen a -20.23% decrease in its stock price over the last five trading sessions. InvestorPlace reported 2024-04-22 that Moolec Science (NASDAQ: MLEC ) stock is taking off on Monday after the company got approval from the Food and Drug Administration (FDA) for its plant-grown animal proteins. According to a press release from the company, this covers its genetically engineered soybean that accumulates animal proteins.
MLEC’s Market Performance
MLEC’s stock has fallen by -20.23% in the past week, with a monthly rise of 2.99% and a quarterly drop of -27.75%. The volatility ratio for the week is 17.76% while the volatility levels for the last 30 days are 15.63% for Moolec Science SA The simple moving average for the last 20 days is -0.84% for MLEC stock, with a simple moving average of -42.95% for the last 200 days.
Analysts’ Opinion of MLEC
Many brokerage firms have already submitted their reports for MLEC stocks, with ROTH MKM repeating the rating for MLEC by listing it as a “Buy.” The predicted price for MLEC in the upcoming period, according to ROTH MKM is $5 based on the research report published on September 27, 2023 of the previous year 2023.
MLEC Trading at -9.80% from the 50-Day Moving Average
After a stumble in the market that brought MLEC to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -68.64% of loss for the given period.
Volatility was left at 15.63%, however, over the last 30 days, the volatility rate increased by 17.76%, as shares sank -0.72% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -28.83% lower at present.
During the last 5 trading sessions, MLEC fell by -20.81%, which changed the moving average for the period of 200-days by -60.06% in comparison to the 20-day moving average, which settled at $1.3912. In addition, Moolec Science SA saw -43.90% in overturn over a single year, with a tendency to cut further losses.
Stock Fundamentals for MLEC
Current profitability levels for the company are sitting at:
- -1.81 for the present operating margin
- 0.02 for the gross margin
The net margin for Moolec Science SA stands at -2.24. The total capital return value is set at -0.4.
Based on Moolec Science SA (MLEC), the company’s capital structure generated 0.55 points at debt to capital in total, while cash flow to debt ratio is standing at -1.59. The debt to equity ratio resting at 1.2. The interest coverage ratio of the stock is -25.86.
Currently, EBITDA for the company is -52.08 million with net debt to EBITDA at -0.97. When we switch over and look at the enterprise to sales, we see a ratio of 20.07. The receivables turnover for the company is 2.41for trailing twelve months and the total asset turnover is 0.14. The liquidity ratio also appears to be rather interesting for investors as it stands at 0.43.
Conclusion
In conclusion, Moolec Science SA (MLEC) has had a bad performance lately. Opinion on the stock among analysts is mixed, with some giving it a “buy” rating and others a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
